These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23444494)

  • 21. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
    O'Connor ED; Fraser JF
    Crit Care Resusc; 2006 Dec; 8(4):345-52. PubMed ID: 17227274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
    Matthai WH
    Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia.
    Faratro R; D'Gama C; Chan C
    CANNT J; 2008; 18(4):32-5. PubMed ID: 19175190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia and thrombosis.
    Patel VP; Bong M; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin induced thrombocytopenia: diagnosis and management update.
    Ahmed I; Majeed A; Powell R
    Postgrad Med J; 2007 Sep; 83(983):575-82. PubMed ID: 17823223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 36. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
    Magnani HN; Gallus A
    Thromb Haemost; 2006 Jun; 95(6):967-81. PubMed ID: 16732376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
    von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
    Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.